Selective Tibial Nerve Block vs Local Infiltration Analgesia After Prothetic Knee Surgery
Tracking Information | |||
---|---|---|---|
First Submitted Date ICMJE | October 2, 2018 | ||
First Posted Date ICMJE | October 5, 2018 | ||
Last Update Posted Date | October 5, 2018 | ||
Actual Study Start Date ICMJE | November 1, 2018 | ||
Estimated Primary Completion Date | November 1, 2020 (Final data collection date for primary outcome measure) | ||
Current Primary Outcome Measures ICMJE |
Total morphine consumption (mg)[ Time Frame: 24 hours postoperatively ] |
||
Original Primary Outcome Measures ICMJE | Same as current | ||
Current Secondary Outcome Measures ICMJE |
|
||
Descriptive Information | |||
Brief Title ICMJE | Selective Tibial Nerve Block vs Local Infiltration Analgesia After Prothetic Knee Surgery |
||
Official Title ICMJE | Optimal Pain Control After Prothetic Knee Surgery Either by Selective Tibial Nerve Block Versus Local Infiltration Analgesia |
||
Brief Summary | Patient suffer from moderate posterior knee pain after TKA despite injection of local anesthetic around the femoral nerve (femoral nerve block). Indeed, the posterior part of the knee is innervated by the sciatic nerve. This nerve is not routinely blocked as clinicians fear to produce a motor block of the leg that might impair the postoperative assessment. An analgesic alternative is the infiltration of the knee with local anesthetics performed by the surgeon. Recently a trial(1) demonstrated that a selective tibial nerve block provides an effective analgesia without a motor blockage when compared with a sciatic nerve block. The objective of this randomized controlled double-blinded trial is to assess whether a tibial nerve block is more effective for the postoperative pain than local infiltration analgesia when there are combined with a femoral nerve block, without decreasing the functional parameters. |
||
Detailed Description | |||
Study Type ICMJE | Interventional | ||
Study Phase | N/A | ||
Study Design ICMJE | Allocation: Randomized Intervention Model: Parallel Assignment Intervention Model Description: Masking: Interventional Masking Description: Primary Purpose: Treatment |
||
Condition ICMJE | |||
Intervention ICMJE |
|
||
Study Arms |
|
||
Recruitment Information | |||
Recruitment Status ICMJE | Not yet recruiting | ||
Estimated Enrollment ICMJE |
60 | ||
Original Estimated Enrollment ICMJE | Same as current | ||
Estimated Study Completion Date | November 1, 2021 | ||
Estimated Primary Completion Date | November 1, 2020 (Final data collection date for primary outcome measure) | ||
Eligibility Criteria ICMJE | Inclusion Criteria: - Patient scheduled for a total knee arthroplasty under spinal block. - Patient with a weight above 40kg. Exclusion Criteria: - Patient with ASA IV status. - Contraindication to spinal block, femoral nerve block or tibial nerve block. - Neurological deficit of the lower limb. - Patient with renal dysfunction. - Patient with chronic pain, opioid consumption or alcohol consumption. - Pregnancy. | ||
Sex/Gender |
|
||
Ages | 18 Years and older (Adult, Older Adult) | ||
Accepts Healthy Volunteers | No | ||
Listed Location Countries ICMJE | |||
Removed Location Countries | |||
Administrative Information | Has Data Monitoring Committee | Yes | |
U.S. FDA-regulated Product |
Studies a U.S. FDA-regulated Drug Product: No Studies a U.S. FDA-regulated Device Product: No |
||
IPD Sharing Statement |
|
||
Responsible Party | Eric Albrecht,Centre Hospitalier Universitaire Vaudois | ||
Study Sponsor ICMJE | Centre Hospitalier Universitaire Vaudois | ||
Collaborators ICMJE | |||
Investigators ICMJE |
|
||
PRS Account | Centre Hospitalier Universitaire Vaudois | ||
Verification Date | October 2018 | ||
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP |